Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Post-operative Pain in Gastric Bypass
NCT03187379Phase 4Completed
- Start
- Jun 2017
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms). Primary endpoint: Post-Operative Pain at 24 Hours. Started Jun 2017; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03187379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187379.